Filing
Spy
Filing
Spy
Home
About
DNDN
Dendreon Corporation
Biotechnology company developing immunotherapy for prostate cancer
CUSIP: 24823Q107
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2014 Q1
1 of 5 quarters
Total Value
$7.28M
Total Shares
2.43M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Miller Value Partners
$7.28M
2.43M
0.3%
Unchanged
Miller Value Partners
$7.28M
2.43M shares
Unchanged
DNDN — Dendreon Corporation - FilingSpy